HUP0203159A3 - Method for producing liposome preparation, containing pipecolic acid derivative - Google Patents

Method for producing liposome preparation, containing pipecolic acid derivative

Info

Publication number
HUP0203159A3
HUP0203159A3 HU0203159A HUP0203159A HUP0203159A3 HU P0203159 A3 HUP0203159 A3 HU P0203159A3 HU 0203159 A HU0203159 A HU 0203159A HU P0203159 A HUP0203159 A HU P0203159A HU P0203159 A3 HUP0203159 A3 HU P0203159A3
Authority
HU
Hungary
Prior art keywords
acid derivative
pipecolic acid
liposome preparation
producing liposome
containing pipecolic
Prior art date
Application number
HU0203159A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of HUP0203159A2 publication Critical patent/HUP0203159A2/hu
Publication of HUP0203159A3 publication Critical patent/HUP0203159A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
HU0203159A 1999-10-18 2000-10-03 Method for producing liposome preparation, containing pipecolic acid derivative HUP0203159A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29583499 1999-10-18
PCT/JP2000/006852 WO2001028522A2 (en) 1999-10-18 2000-10-03 Method for producing liposome preparation

Publications (2)

Publication Number Publication Date
HUP0203159A2 HUP0203159A2 (hu) 2002-12-28
HUP0203159A3 true HUP0203159A3 (en) 2004-12-28

Family

ID=17825797

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203159A HUP0203159A3 (en) 1999-10-18 2000-10-03 Method for producing liposome preparation, containing pipecolic acid derivative

Country Status (13)

Country Link
US (1) US6979461B1 (hu)
EP (1) EP1221938A2 (hu)
JP (1) JP2003512314A (hu)
KR (1) KR20020063873A (hu)
CN (1) CN1411368A (hu)
AR (1) AR026076A1 (hu)
AU (1) AU7452900A (hu)
BR (1) BR0015053A (hu)
CA (1) CA2386155A1 (hu)
HU (1) HUP0203159A3 (hu)
MX (1) MXPA02003846A (hu)
RU (1) RU2002113171A (hu)
WO (1) WO2001028522A2 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
ES2564194T3 (es) 2005-02-09 2016-03-18 Santen Pharmaceutical Co., Ltd. Formulaciones líquidas para el tratamiento de enfermedades o dolencias
ITMI20051826A1 (it) * 2005-09-29 2007-03-30 Novachem S A Kit per la somministrazione parenterale di medicamenti
BRPI0707612B8 (pt) * 2006-02-09 2021-05-25 Macusight Inc vaso lacrado e formulações líquidas contidas no mesmo
AU2013200089B2 (en) * 2006-02-09 2016-03-03 Santen Pharmaceutical Co., Ltd Stable formulations, and methods of their preparation and use
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
US8906397B2 (en) 2011-02-07 2014-12-09 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
US20120201871A1 (en) * 2011-02-07 2012-08-09 Professional Compounding Centers Of America, Ltd. Permeation enhancers with liposomes for topical formulations
US8871811B2 (en) 2011-02-07 2014-10-28 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
EP3351245A4 (en) * 2015-09-18 2019-05-22 Nippon Kayaku Kabushiki Kaisha PHARMACEUTICAL COMPOSITION COMPRISING RAPAMYCIN OR A DERIVATIVE THEREOF
CN110151590A (zh) * 2019-06-19 2019-08-23 湖州浦瑞生物医药技术有限公司 视黄醇视黄酸酯纳米制剂及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532130A (en) 1981-07-06 1985-07-30 Rush-Presbyterian-St. Luke's Medical Center Preparation of synthetic frythrocytes
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US5096629A (en) 1988-08-29 1992-03-17 501 Nippon Fine Chemical Co., Ltd. Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
CA2110490C (en) 1991-06-18 2008-07-29 Evan C. Unger Drug delivery systems comprising gas-filled liposomes at least 90% devoid of liquid in their interior
EP0658344B1 (en) * 1991-10-31 2000-01-05 Fujisawa Pharmaceutical Co., Ltd. Liposome preparation containing tricyclic compound
JP3329554B2 (ja) * 1993-03-10 2002-09-30 千葉製粉株式会社 乾燥小胞体

Also Published As

Publication number Publication date
CA2386155A1 (en) 2001-04-26
AR026076A1 (es) 2002-12-26
WO2001028522A3 (en) 2002-05-10
JP2003512314A (ja) 2003-04-02
KR20020063873A (ko) 2002-08-05
CN1411368A (zh) 2003-04-16
RU2002113171A (ru) 2004-01-27
MXPA02003846A (es) 2002-09-30
BR0015053A (pt) 2002-07-02
EP1221938A2 (en) 2002-07-17
AU7452900A (en) 2001-04-30
HUP0203159A2 (hu) 2002-12-28
WO2001028522A2 (en) 2001-04-26
US6979461B1 (en) 2005-12-27

Similar Documents

Publication Publication Date Title
IL150542A0 (en) Method for preparing hydroxypicolinic acid derivatives
HK1042647A1 (zh) 製備膜囊的方法
HUP0103659A2 (en) Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives
AU5882299A (en) Process for preparing lactic acid
AU2001233034A1 (en) Method for preparing alpha-sulfonyl hydroxamic acid derivatives
HUP0203159A3 (en) Method for producing liposome preparation, containing pipecolic acid derivative
AU2001227086A1 (en) Process for preparing 2-hydroxy-4-methylthiobutanoic acid
HUP0004884A3 (en) Process for preparing 1,4-dihydropyridine derivatives
AU2324000A (en) Process for producing 2-hydroxy-4-methyl-thiobutanoic acid
IL148330A0 (en) Process for preparing phenylacetic acid derivatives
IL144828A0 (en) A pipecolic acid derivative containing liposome composition
AU2842799A (en) Novel method for preparing fexofenadine
AU3818900A (en) Process for the preparation of substituted piperidines
PL349857A1 (en) Method for producing film-type dosage forms
IL146573A0 (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
HU0004005D0 (en) Method for producing (+)-trans-chrysant-henummonocarboxylic acid
PL356988A1 (en) Method for making adipic acid
AU1283001A (en) Method for producing alkylhalogenosilanes
HK1042078A1 (en) Method for producing robenidine or derivatives thereof
IL147804A0 (en) Method for producing 4-cyano-2-aminomethylthiazol
AU5135600A (en) Process for producing piperidine
AU1141501A (en) Method for producing hydroxymethylpyridines
HUP0004469A3 (en) Process for producing trifluormethyl-aniline derivatives
IL134912A0 (en) Method for preparing 1-phenylpyrrazolin-3-carboxylic acid derivatives
IL147769A0 (en) Method for producing 2-aminomethyl-4-cyano-thiazol

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees